106 related articles for article (PubMed ID: 10860888)
1. Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity.
Brand D; Lemiale F; Thibault G; Verrier B; Lebigot S; Roingeard P; Buzelay L; Brunet S; Barin F
Virology; 2000 Jun; 271(2):350-62. PubMed ID: 10860888
[TBL] [Abstract][Full Text] [Related]
2. The transmembrane protein of HIV-1 primary isolates modulates cell surface expression of their envelope glycoproteins.
Lebigot S; Roingeard P; Thibault G; Lemiale F; Verrier B; Barin F; Brand D
Virology; 2001 Nov; 290(1):136-42. PubMed ID: 11882998
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
Notka F; Stahl-Hennig C; Dittmer U; Wolf H; Wagner R
Biol Chem; 1999 Mar; 380(3):341-52. PubMed ID: 10223337
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates: a comparative study using multivalent vaccine approaches.
Lemiale F; Brand D; Lebigot S; Verrier B; Buzelay L; Brunet S; Barin F
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):413-22. PubMed ID: 11391160
[TBL] [Abstract][Full Text] [Related]
5. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.
Pancera M; Wyatt R
Virology; 2005 Feb; 332(1):145-56. PubMed ID: 15661147
[TBL] [Abstract][Full Text] [Related]
6. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
[TBL] [Abstract][Full Text] [Related]
7. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
Hernández M; Pozo L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
Chang SY; Vithayasai V; Vithayasai P; Essex M; Lee TH
J Infect Dis; 2000 Aug; 182(2):442-50. PubMed ID: 10915074
[TBL] [Abstract][Full Text] [Related]
9. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
[TBL] [Abstract][Full Text] [Related]
10. Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies.
Altmeyer R; Mordelet E; Girard M; Vidal C
Virology; 1999 Jul; 259(2):314-23. PubMed ID: 10388656
[TBL] [Abstract][Full Text] [Related]
11. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
Kuribayashi H; Wakabayashi A; Shimizu M; Kaneko H; Norose Y; Nakagawa Y; Wang J; Kumagai Y; Margulies DH; Takahashi H
Biochem Biophys Res Commun; 2004 Apr; 316(2):356-63. PubMed ID: 15020225
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1.
Jeffs SA; Goriup S; Kebble B; Crane D; Bolgiano B; Sattentau Q; Jones S; Holmes H
Vaccine; 2004 Feb; 22(8):1032-46. PubMed ID: 15161081
[TBL] [Abstract][Full Text] [Related]
13. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis].
Chen Y; Garcia R; Baralle FE
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506
[TBL] [Abstract][Full Text] [Related]
14. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
15. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.
Liu F; Mboudjeka I; Shen S; Chou TH; Wang S; Ross TM; Lu S
Vaccine; 2004 Apr; 22(13-14):1764-72. PubMed ID: 15068860
[TBL] [Abstract][Full Text] [Related]
16. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.
Gao F; Weaver EA; Lu Z; Li Y; Liao HX; Ma B; Alam SM; Scearce RM; Sutherland LL; Yu JS; Decker JM; Shaw GM; Montefiori DC; Korber BT; Hahn BH; Haynes BF
J Virol; 2005 Jan; 79(2):1154-63. PubMed ID: 15613343
[TBL] [Abstract][Full Text] [Related]
17. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
18. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
[TBL] [Abstract][Full Text] [Related]
19. Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120.
Berkower I; Raymond M; Muller J; Spadaccini A; Aberdeen A
Virology; 2004 Mar; 321(1):75-86. PubMed ID: 15033567
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles.
Brand D; Lemiale F; Turbica I; Buzelay L; Brunet S; Barin F
AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1369-77. PubMed ID: 9788678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
